Status:

COMPLETED

A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Lead Sponsor:

Organon and Co

Conditions:

Hyperlipidemia

Hypercholesterolemia

Eligibility:

All Genders

18-79 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to assess the cholesterol lowering effects of an investigational drug in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

Eligibility Criteria

Inclusion

  • Men and women 18-79 years of age with high cholesterol and high triglycerides.

Exclusion

  • Individuals who do not meet specific cholesterol or triglyceride levels as required by the study.

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2005

Estimated Enrollment :

611 Patients enrolled

Trial Details

Trial ID

NCT00093899

Start Date

November 1 2004

End Date

September 1 2005

Last Update

August 15 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) | DecenTrialz